Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole vs Voriconazole for Invasive Aspergillosis (Phase 3)
CTR20150262Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of posaconazole in invasive aspergillosis (IA), sponsored by Merck & Co.. Started Jul 2016; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on CTR20150262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150262.